Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies

BACKGROUND: COVID-19 vaccination is highly recommended to multiple sclerosis (MS) patients. Little is known about the role of patients’ clinical and demographic characteristics in determining antibody response. METHODS: We evaluated safety and efficacy of anti-SARS-CoV-2 vaccines on 143 included MS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellinvia, Angelo, Aprea, Maria Grazia, Portaccio, Emilio, Pastò, Luisa, Razzolini, Lorenzo, Fonderico, Mattia, Addazio, Ilaria, Betti, Matteo, Amato, Maria Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345744/
https://www.ncbi.nlm.nih.gov/pubmed/35918574
http://dx.doi.org/10.1007/s10072-022-06287-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345744/
https://www.ncbi.nlm.nih.gov/pubmed/35918574
http://dx.doi.org/10.1007/s10072-022-06287-2

Ejemplares similares